LLY250103P915000
- 0.00
- 0.000.00%
Eli Lilly and Co Newsroom
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
BofA's Growth 10 Screen as January 2025 Trade Revs up
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Is Eli Lilly and Company (NYSE:LLY) Among Israel Englander's Top Stock Picks Heading Into 2025?
J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100
Express News | Orbis Medicines: Financing Led by Nea With Participation From Eli Lilly, Export and Investment Fund of Denmark, Novo Holdings, Forbion, Others
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.50
Novo Nordisk Seeks to Block Compounded Victoza
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Smart Money Is Betting Big In LLY Options
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
Santa Claus Came Without Rallying the Troops | Live Stock
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
Eli Lilly and Company (LLY) Is Attracting Investor Attention: Here Is What You Should Know
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
The 15.92% Average Gain in Inauguration Year: Will Trump's Second Term Echo the Trend?
Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks